153 related articles for article (PubMed ID: 33223243)
1. Polyelectrolyte complex templated synthesis of monodisperse, sub-100 nm porous silica nanoparticles for cancer targeted and stimuli-responsive drug delivery.
Newham G; Mathew RK; Wurdak H; Evans SD; Ong ZY
J Colloid Interface Sci; 2021 Feb; 584():669-683. PubMed ID: 33223243
[TBL] [Abstract][Full Text] [Related]
2. Co-loading of photothermal agents and anticancer drugs into porous silicon nanoparticles with enhanced chemo-photothermal therapeutic efficacy to kill multidrug-resistant cancer cells.
Xia B; Zhang Q; Shi J; Li J; Chen Z; Wang B
Colloids Surf B Biointerfaces; 2018 Apr; 164():291-298. PubMed ID: 29413608
[TBL] [Abstract][Full Text] [Related]
3. Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted Delivery of Doxorubicin to Glioblastoma.
Luo M; Lewik G; Ratcliffe JC; Choi CHJ; Mäkilä E; Tong WY; Voelcker NH
ACS Appl Mater Interfaces; 2019 Sep; 11(37):33637-33649. PubMed ID: 31433156
[TBL] [Abstract][Full Text] [Related]
4. Near-infrared light and magnetic field dual-responsive porous silicon-based nanocarriers to overcome multidrug resistance in breast cancer cells with enhanced efficiency.
Li J; Zhang W; Gao Y; Tong H; Chen Z; Shi J; Santos HA; Xia B
J Mater Chem B; 2020 Jan; 8(3):546-557. PubMed ID: 31854435
[TBL] [Abstract][Full Text] [Related]
5. Iron-silicate-coated porous silicon nanoparticles for in situ ROS self-generation.
Um H; Kang RH; Kim D
Colloids Surf B Biointerfaces; 2023 May; 225():113273. PubMed ID: 36965332
[TBL] [Abstract][Full Text] [Related]
6. pH-responsive poly (acrylic acid)-gated mesoporous silica and its application in oral colon targeted drug delivery for doxorubicin.
Tian B; Liu S; Wu S; Lu W; Wang D; Jin L; Hu B; Li K; Wang Z; Quan Z
Colloids Surf B Biointerfaces; 2017 Jun; 154():287-296. PubMed ID: 28351801
[TBL] [Abstract][Full Text] [Related]
7. Porous Silicon Nanocarriers with Stimulus-Cleavable Linkers for Effective Cancer Therapy.
Xue Y; Bai H; Peng B; Tieu T; Jiang J; Hao S; Li P; Richardson M; Baell J; Thissen H; Cifuentes A; Li L; Voelcker NH
Adv Healthc Mater; 2022 Jun; 11(12):e2200076. PubMed ID: 35306736
[TBL] [Abstract][Full Text] [Related]
8. Free-Standing Hierarchically Porous Silica Nanoparticle Superstructures: Bridging the Nano- to Microscale for Tailorable Delivery of Small and Large Therapeutics.
Palvai S; Kpeglo D; Newham G; Peyman SA; Evans SD; Ong ZY
ACS Appl Mater Interfaces; 2024 Feb; 16(5):5568-5581. PubMed ID: 38270578
[TBL] [Abstract][Full Text] [Related]
9. Study of pH-Responsive and Polyethylene Glycol-Modified Doxorubicin-Loaded Mesoporous Silica Nanoparticles for Drug Delivery.
Qin Y; Shan X; Han Y; Jin H; Gao Y
J Nanosci Nanotechnol; 2020 Oct; 20(10):5997-6006. PubMed ID: 32384944
[TBL] [Abstract][Full Text] [Related]
10. The thermal/pH-sensitive drug delivery system encapsulated by PAA based on hollow hybrid nanospheres with two silicon source.
Zhang K; Zhang Y; Li Y; Iqbal Z; Yu L; Liu J; Wang H; He P
J Biomater Sci Polym Ed; 2021 Apr; 32(6):695-713. PubMed ID: 33297850
[TBL] [Abstract][Full Text] [Related]
11. Pollen-like silica nanoparticles as a nanocarrier for tumor targeted and pH-responsive drug delivery.
Jin R; Wang J; Gao M; Zhang X
Talanta; 2021 Aug; 231():122402. PubMed ID: 33965051
[TBL] [Abstract][Full Text] [Related]
12. Cancer-targeting siRNA delivery from porous silicon nanoparticles.
Wan Y; Apostolou S; Dronov R; Kuss B; Voelcker NH
Nanomedicine (Lond); 2014 Oct; 9(15):2309-21. PubMed ID: 24593001
[TBL] [Abstract][Full Text] [Related]
13. Hollow Mesoporous Silica@Metal-Organic Framework and Applications for pH-Responsive Drug Delivery.
Jia X; Yang Z; Wang Y; Chen Y; Yuan H; Chen H; Xu X; Gao X; Liang Z; Sun Y; Li JR; Zheng H; Cao R
ChemMedChem; 2018 Mar; 13(5):400-405. PubMed ID: 29337422
[TBL] [Abstract][Full Text] [Related]
14. Photoluminescent and biodegradable porous silicon nanoparticles for biomedical imaging.
Park Y; Yoo J; Kang MH; Kwon W; Joo J
J Mater Chem B; 2019 Nov; 7(41):6271-6292. PubMed ID: 31393507
[TBL] [Abstract][Full Text] [Related]
15. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
[TBL] [Abstract][Full Text] [Related]
16. Nanobody-displaying porous silicon nanoparticles for the co-delivery of siRNA and doxorubicin.
Tieu T; Wojnilowicz M; Huda P; Thurecht KJ; Thissen H; Voelcker NH; Cifuentes-Rius A
Biomater Sci; 2021 Jan; 9(1):133-147. PubMed ID: 33135714
[TBL] [Abstract][Full Text] [Related]
17. Photothermal and biodegradable polyaniline/porous silicon hybrid nanocomposites as drug carriers for combined chemo-photothermal therapy of cancer.
Xia B; Wang B; Shi J; Zhang Y; Zhang Q; Chen Z; Li J
Acta Biomater; 2017 Mar; 51():197-208. PubMed ID: 28069501
[TBL] [Abstract][Full Text] [Related]
18. Reduction-responsive drug delivery based on mesoporous silica nanoparticle core with crosslinked poly(acrylic acid) shell.
Li H; Zhang JZ; Tang Q; Du M; Hu J; Yang D
Mater Sci Eng C Mater Biol Appl; 2013 Aug; 33(6):3426-31. PubMed ID: 23706230
[TBL] [Abstract][Full Text] [Related]
19. Polyacrylic acid modified upconversion nanoparticles for simultaneous pH-triggered drug delivery and release imaging.
Jia X; Yin J; He D; He X; Wang K; Chen M; Li Y
J Biomed Nanotechnol; 2013 Dec; 9(12):2063-72. PubMed ID: 24266261
[TBL] [Abstract][Full Text] [Related]
20. Tumor targeted delivery of umbelliferone via a smart mesoporous silica nanoparticles controlled-release drug delivery system for increased anticancer efficiency.
Kundu M; Chatterjee S; Ghosh N; Manna P; Das J; Sil PC
Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111239. PubMed ID: 32806268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
